Search - tctmd.com

Displaying 61 - 80 of 4296

Sort: Relevancy | Date

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

Presenter: Konstantinos Voudris

October 30, 2024

Presentation TCT 2024

TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis

Presenter: Rob Eerdekens

October 30, 2024

Presentation TCT 2024

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

Presenter: Paul Sorajja

October 30, 2024

Presentation TCT 2024

TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress

Presenter: Rob Eerdekens

October 30, 2024

Presentation TCT 2024

TCT 1359: Management Strategies of Paravalvular Leak in the Post-TAVR Patient: ?To Plug or to Balloon?

Presenter: Mariah Mascara

October 30, 2024

Presentation TCT 2024

TCT 1190: Hostile Aorta: Valve, Grafts, Stents and Plug for Intervention

Presenter: Diego Bianchi

October 30, 2024

Presentation TCT 2024

TCT 1203: First Report of Intravenous Thrombolysis for the Treatment of Severe Aortic Insufficiency Following Transcatheter Aortic Valve Replacement

Presenter: Dhiran Verghese

October 30, 2024

Presentation TCT 2024

Lessons Learned From the SMART Trial

Presenter: Howard Herrmann

October 30, 2024

Presentation TCT 2024

TCT 1290: Transcatheter Rescue Thrombectomy of a Stuck Prosthetic Mitral Valve: A Desperate Measure and a Race Against Time

Presenter: Vidhyakar Rangasamy Balasubramanian

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate!

Presenter: Adam Greenbaum

October 30, 2024

Presentation TCT 2024

Re-Do Surgery has Clear Long-Term Advantages and is Preferred!

Presenter: Michael Bowdish

October 30, 2024

Presentation TCT 2024

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Presenter: Jaffar Khan

October 30, 2024

Presentation TCT 2024

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

Presenter: Danny Dvir

October 30, 2024

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Presentation TCT 2024

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

Presenter: Marco Ancona

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Presenter: Santiago Garcia

October 30, 2024

Advertisement

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

TCT 1377: Mitral Valve Transcatheter Edge-to-Edge Repair for Hypertrophic Obstructive Cardiomyopathy

TCT 655: Hemodynamic Effects of Aortic Banding to Simulate Progressive Aortic Stenosis

Transcatheter Tricuspid Edge-To-Edge-Repair – Updates from TRILUMINATE and TRI-FR

TCT 854: Physiologic Response of Normal Aortic Valves During Dobutamine Stress

TCT 1359: Management Strategies of Paravalvular Leak in the Post-TAVR Patient: ?To Plug or to Balloon?

TCT 1190: Hostile Aorta: Valve, Grafts, Stents and Plug for Intervention

TCT 1203: First Report of Intravenous Thrombolysis for the Treatment of Severe Aortic Insufficiency Following Transcatheter Aortic Valve Replacement

Lessons Learned From the SMART Trial

TCT 1290: Transcatheter Rescue Thrombectomy of a Stuck Prosthetic Mitral Valve: A Desperate Measure and a Race Against Time

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate!

Re-Do Surgery has Clear Long-Term Advantages and is Preferred!

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content